We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Guerbet Aims for Global Medical Imaging Leadership by Acquisition of Mallinckrodt’s CMDS Business

By HospiMedica International staff writers
Posted on 28 Jul 2015
Guerbet (Paris, France) has announced a definitive agreement for the acquisition of the Contrast Media and Delivery Systems (CMDS) business of pharmaceutical giant Mallinckrodt (Chesterfield, Derbyshire, UK).

The acquisition gave Guerbet and the CMDS unit combined pro-forma sales of nearly EUR 800 million in 2014, a total of 2,500 employees worldwide, production sites in Ireland and in North America, and a global distribution network in nearly 65 countries. More...
CMDS also includes various delivery systems and imaging solutions for X-ray cardiac and vascular imaging, X-ray scanners, Magnetic Resonance Imaging (MRI), and urological imaging systems. The CMDS business offers the contrast media Optiray and Optiject/Ultraject in X-ray, and syringe-based delivery systems. Guerbet provides the MRI contrast media Dotarem, hydraulic injection techniques for softbags.

Guerbet is acquiring 100% of the CMDS business in a transaction valued at about USD 270 million, and pending customary closing conditions is expected to close before the end of 2015. CMDS has a strong presence in the US and Guerbet in Europe. Guerbet is also planning to expand its presence in China, Russia and Turkey, and other markets with high growth potential.

Yves L’Epine, CEO of Guerbet, said, “This acquisition transforms and accelerates Guerbet’s future: it doubles our turnover, enables us to extend our geographical footprint and creates complementarities in both contrast media and imaging solutions and services. We will be very pleased to welcome Mallinckrodt’s CMDS colleagues to successfully and rapidly complete this integration together after the closing and create a new global leader in medical imaging.”

Related Links:

Guerbet
Mallinckrodt



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.